Inogen (INGN) Tax Provisions (2013 - 2026)
Inogen's (INGN) quarterly Tax Provisions came in at -$174000.0 in Q1 2026, down 79.38% year-on-year from -$843900.0 in Q1 2025, and down 121.7% on a QoQ basis from $802000.0 in Q4 2025.
Inogen (INGN) Tax Provisions (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Tax Provisions data on file, last reported at -$174000.0 in Q1 2026.
- On a quarterly basis, Tax Provisions fell 79.38% year-over-year to -$174000.0 in Q1 2026; TTM through Mar 2026 was $329000.0, a 30.74% decrease from a year earlier, with the FY2025 full-year figure at $406000.0, down 3.79% from the prior year.
- Tax Provisions for Q1 2026 stood at -$174000.0, down from $802000.0 in the prior quarter.
- Over the last five years, Tax Provisions for INGN reached as high as $802000.0 in Q4 2025 and fell as low as -$533000.0 in Q4 2023.
- Historically, Tax Provisions has averaged $74294.1 across 5 years, with a median of $41000.0 in 2023.
- Across the five-year window, Tax Provisions soared 472.86% in 2023 and sank 2085.71% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $141000.0 in 2022, then slumped by 478.01% to -$533000.0 in 2023, then jumped by 227.58% to $680000.0 in 2024, then rose by 17.94% to $802000.0 in 2025, then plunged by 121.7% to -$174000.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were -$174000.0 in Q1 2026, $802000.0 in Q4 2025, and -$146000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 372.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 105.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 575.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -176.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 70.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 94.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | -174,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -174,000.00 |
| Dec 31, 2025 | 802,000.00 |
| Sep 30, 2025 | -146,000.00 |
| Jun 30, 2025 | -153,000.00 |
| Mar 31, 2025 | -97,000.00 |
| Dec 31, 2024 | 680,000.00 |
| Sep 30, 2024 | -101,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | -150,000.00 |
| Dec 31, 2023 | -533,000.00 |
| Sep 30, 2023 | 401,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 196,000.00 |
| Dec 31, 2022 | 141,000.00 |
| Sep 30, 2022 | 70,000.00 |
| Jun 30, 2022 | 69,000.00 |
| Mar 31, 2022 | 224,000.00 |
| Dec 31, 2021 | 15.99 Mn |
| Sep 30, 2021 | -6.25 Mn |
| Jun 30, 2021 | 6.90 Mn |